Article

Somatic Mutations of the HER2 Kinase Domain in Lung Adenocarcinomas

2006-01-01

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: df08c1e5-a9fb-5b3f-88a0-f07f618a1588
DOI: 10.1016/s1040-1741(08)70160-x

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Somatic Mutations of the HER2 Kinase Domain in Lung AdenocarcinomasDOI 10.1016/s1040-1741(08)70160-xRead

Somatic mutations of the HER2 kinase domain in lung adenocarcinomas.Semantic proximity Read

HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium.Semantic proximity Read

Somatic mutations affect key pathways in lung adenocarcinomaSemantic proximity Read

Lung Cancer That Harbors an <i>HER2</i> Mutation: Epidemiologic Characteristics and Therapeutic PerspectivesSemantic proximity Read

[Current management and future prospect of HER-2 mutant non-small cell lung cancer].Semantic proximity Read

Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers.Semantic proximity Read

HER2 Mutations in Non–Small-Cell Lung Cancer Can Be Continually TargetedSemantic proximity Read

Mutational analysis of EGFR and related signaling pathway genes in lung adenocarcinomas identifies a novel somatic kinase domain mutation in FGFR4.Semantic proximity Read

HER family kinase domain mutations promote tumor progression and can predict response to treatment in human breast cancer.Semantic proximity Read

Lung cancer: intragenic ERBB2 kinase mutations in tumours.Semantic proximity Read

Lung Adenocarcinomas with HER2-Activating Mutations Are Associated with Distinct Clinical Features and HER2/EGFR Copy Number GainsSemantic proximity Read

Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast CancerSemantic proximity Read